Curaleaf Holdings (CURLF) Non-Current Deffered Revenue (2022 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Non-Current Deffered Revenue of $2.0 million for Q4 2024, down 90.61% year-on-year from $21.3 million in Q1 2024, and down 91.58% on a QoQ basis from $23.7 million in Q3 2024.

Curaleaf Holdings (CURLF) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Non-Current Deffered Revenue for 3 consecutive years, with $2.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Non-Current Deffered Revenue fell 90.61% year-over-year to $2.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.0 million (down 90.61% YoY) and the FY2024 annual result came in at $2.0 million, down 90.61% from the prior year.
  • Non-Current Deffered Revenue fell to $2.0 million in Q4 2024 per CURLF's latest filing, from $23.7 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for CURLF reached as high as $40.2 million in Q2 2023 and fell as low as $2.0 million in Q4 2024.
  • A 3-year average of $26.8 million and a median of $23.7 million in 2024 frame the typical range for Non-Current Deffered Revenue.
  • The largest YoY upside for Non-Current Deffered Revenue was 40.96% in 2024 against a maximum downside of 90.61% in 2024.
  • Year by year, Non-Current Deffered Revenue stood at $36.9 million in 2022, then sank by 42.18% to $21.3 million in 2023, then sank by 90.61% to $2.0 million in 2024.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $2.0 million, $23.7 million, and $22.9 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.00 Mn
Sep 30, 2024 23.75 Mn
Jun 30, 2024 22.93 Mn
Dec 31, 2023 21.31 Mn
Sep 30, 2023 40.22 Mn
Jun 30, 2023 40.22 Mn
Dec 31, 2022 36.85 Mn